Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 04:00PM ET
6.32
Dollar change
-0.06
Percentage change
-0.94
%
IndexRUT P/E- EPS (ttm)-0.53 Insider Own21.20% Shs Outstand119.16M Perf Week8.22%
Market Cap773.95M Forward P/E- EPS next Y-0.91 Insider Trans19.76% Shs Float96.50M Perf Month30.58%
Income-61.92M PEG- EPS next Q-0.21 Inst Own74.67% Short Float2.88% Perf Quarter58.40%
Sales112.91M P/S6.85 EPS this Y-68.83% Inst Trans-0.41% Short Ratio3.12 Perf Half Y14.70%
Book/sh0.21 P/B30.45 EPS next Y-0.18% ROA-24.64% Short Interest2.78M Perf Year68.98%
Cash/sh1.48 P/C4.28 EPS next 5Y- ROE-1928.16% 52W Range3.15 - 7.67 Perf YTD25.15%
Dividend Est.- P/FCF- EPS past 5Y36.03% ROI-108.90% 52W High-17.60% Beta-1.02
Dividend TTM- Quick Ratio1.19 Sales past 5Y610.91% Gross Margin92.08% 52W Low100.63% ATR (14)0.39
Dividend Ex-Date- Current Ratio1.19 EPS Y/Y TTM70.26% Oper. Margin-63.91% RSI (14)63.69 Volatility6.42% 6.89%
Employees268 Debt/Eq0.92 Sales Y/Y TTM661.49% Profit Margin-54.84% Recom1.43 Target Price12.86
Option/ShortYes / Yes LT Debt/Eq0.71 EPS Q/Q9.09% Payout- Rel Volume0.89 Prev Close6.38
Sales Surprise-49.85% EPS Surprise-29.03% Sales Q/Q-3.02% EarningsMay 09 BMO Avg Volume892.32K Price6.32
SMA2013.16% SMA509.67% SMA20021.96% Trades Volume797,057 Change-0.94%
Date Action Analyst Rating Change Price Target Change
May-15-24Initiated Wells Fargo Overweight $11
Dec-19-23Upgrade Leerink Partners Market Perform → Outperform $5 → $12
Jul-05-23Initiated Raymond James Outperform $7
May-24-23Downgrade Jefferies Buy → Hold $7 → $5
Dec-15-20Resumed H.C. Wainwright Buy $20
Oct-23-20Initiated RBC Capital Mkts Sector Perform $13
Dec-31-19Downgrade SVB Leerink Outperform → Mkt Perform $33 → $10
Nov-01-19Initiated Guggenheim Buy $43
Jul-15-19Initiated Cowen Market Perform
Apr-17-19Reiterated H.C. Wainwright Buy $49 → $33
May-15-24 07:16AM
May-10-24 04:53PM
02:39PM
May-09-24 07:45AM
07:30AM
07:00AM Loading…
07:00AM
May-07-24 08:30AM
May-02-24 08:30AM
Apr-30-24 08:30AM
Apr-23-24 08:30AM
Mar-27-24 08:30AM
Mar-15-24 08:18AM
Mar-07-24 10:47AM
Mar-06-24 12:51PM
07:51AM
07:30AM Loading…
07:30AM
Feb-28-24 08:30AM
04:16AM
Feb-27-24 08:30AM
Feb-06-24 01:17PM
Jan-31-24 01:21PM
Jan-08-24 08:00AM
Jan-03-24 08:30AM
Dec-15-23 08:30AM
Dec-07-23 07:00AM
Dec-06-23 04:10PM
04:08PM
Nov-22-23 08:30AM
Nov-11-23 12:09PM
Nov-09-23 08:38AM
07:43AM Loading…
07:43AM
07:30AM
Nov-03-23 04:05PM
Sep-29-23 05:47AM
Sep-28-23 04:15PM
Sep-25-23 08:30AM
Sep-06-23 08:30AM
Sep-05-23 07:30AM
Aug-23-23 11:13AM
Aug-17-23 08:44AM
06:40AM
Aug-10-23 12:40PM
Aug-08-23 06:02AM
Aug-04-23 06:45AM
Aug-03-23 08:55AM
07:53AM
07:30AM
Jul-27-23 08:30AM
Jul-06-23 08:40AM
Jun-26-23 08:30AM
Jun-19-23 08:00AM
May-23-23 07:30AM
May-16-23 08:30AM
May-08-23 06:03AM
May-05-23 06:19AM
May-03-23 08:55AM
07:49AM
07:30AM
Apr-26-23 08:30AM
Apr-20-23 08:30AM
Mar-29-23 08:54AM
08:00AM
Mar-24-23 07:36AM
Mar-22-23 08:45AM
07:30AM
Mar-02-23 08:30AM
Feb-14-23 12:00PM
09:35AM
Feb-09-23 04:05PM
Jan-25-23 06:06AM
Jan-13-23 07:26AM
Jan-03-23 05:40AM
Dec-30-22 12:00PM
09:03AM
Dec-19-22 01:04PM
07:37AM
Dec-15-22 09:07AM
06:11AM
Dec-13-22 11:27AM
09:51AM
07:30AM
Nov-10-22 08:45AM
07:30AM
Nov-09-22 08:30AM
Nov-03-22 08:30AM
Oct-17-22 11:27AM
Oct-12-22 02:35PM
01:35PM
Oct-03-22 08:30AM
Sep-28-22 01:30PM
Sep-27-22 08:30AM
Sep-21-22 11:39AM
Sep-20-22 12:44PM
07:30AM
Sep-16-22 08:30AM
Aug-13-22 08:12AM
Aug-11-22 03:18PM
08:45AM
07:30AM
Aug-03-22 06:15PM
Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Moran KyleChief Financial OfficerApr 03 '24Sale6.1715,63096,42133,921Apr 05 08:00 PM
RA CAPITAL MANAGEMENT, L.P.DirectorDec 11 '23Buy5.001,000,0005,000,00019,202,009Dec 13 04:33 PM
GSK plc10% OwnerDec 07 '23Buy5.003,300,00016,500,00013,983,761Jan 30 04:39 PM
Moran KyleChief Financial OfficerAug 23 '23Sale4.7537,062176,11946,120Aug 23 09:15 PM